Delta Air Lines, Vertex Pharmaceuticals, And A Major US Bank Nearing A Breakout Level: CNBC's 'Final Trades'

On CNBC’s "Halftime Report Final Trades," Amy Raskin of Chevy Chase Trust said Vertex Pharmaceuticals Incorporated VRTX, has "done relatively well this year."

Morgan Stanley recently reiterated Vertex Pharmaceuticals with an Equal-Weight and raised the price target from $305 to $340.

Sarat Sethi said Delta Air Lines, Inc. DAL is really doing well, executing well and has positive cash flow. The company is paying down its debt and also raising prices.

Morgan Stanley analyst Ravi Shanker reiterated Delta Air Lines with an Overweight and maintained a $70 price target.

Don’t forget to check out our premarket coverage here

Josh Brown of Ritholtz Wealth Management recommended staying long on JPMorgan Chase & Co. JPM. "I think $145 and above is a breakout level," he added.

JPMorgan Chase is expected to report its second-quarter results on July 14, 2023.

Joseph Terranova of Virtus Investment Partners said The Cooper Companies, Inc. COO is a quality company.

Cooper Companies recently reported better-than-expected results for its second quarter.

Price Action: Cooper Companies shares fell 0.4% to settle at $375.79, while 375.79 shares fell 1% to close at $143.21 on Thursday. Delta shares fell 2.5% to close at $47.33, while Vertex Pharmaceuticals declined 0.7% to settle at $345.76 during Thursday’s session.

Check This Out: Costco, AZZ And 3 Stocks To Watch Heading Into Friday

Photo: Shutterstock